Aznavour, Yana
Navarrete, Felipe
Badreddine, Jad
Simon, Paul H. G.
Gowda, Vrushab
Rhodes, Stephen
Abou Ghayda, Ramy
Article History
Received: 29 August 2022
Accepted: 26 October 2022
First Online: 15 November 2022
Declarations
:
: Western Institutional Review Board Copernicus Group IRB approval was obtained (Study # 1317234) for this retrospective study. Written informed consent was obtained directly from all patients included in the study. All methods were carried out in accordance with relevant guidelines and regulations.
: Not applicable.
: The authors declare that they have no competing interests. Yana Aznavour, Jad Badreddine and Stephen Rhodes have no financial and personal relationships to disclose. Ramy Abou Ghayda, Felipe Navarrete, Vrushab Gowda, and Paul Simon are, respectively, the Chief Medical Officer, Head of Research and Development, Head of Regulatory Affairs, and VP of Operations at Give Legacy, Inc. The authors declare that they have no competing interests related to the research described in this paper. They did not receive any additional funding, or financial or nonfinancial gain associated with this research. GiveLegacy, Inc. did not intervene nor influence the design, outcomes, materials, methods, or results of this manuscript. There is no direct or indirect gain for GiveLegacy, Inc. in relation to the publication of this study.